Related news from
Sun, 12 May 2024 12:22:42 +0000	Analysts Are Upgrading BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results BioLife Solutions, Inc. ( NASDAQ:BLFS ) just released its quarterly report and things are looking bullish. Revenue...
Fri, 10 May 2024 16:37:13 +0000	BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript May 9, 2024 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.26. BLFS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the BioLife Solutions First […]
Thu, 09 May 2024 22:05:07 +0000	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates BioLife Solutions (BLFS) delivered earnings and revenue surprises of 26.92% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Thu, 09 May 2024 20:03:00 +0000	BioLife Solutions Reports First Quarter 2024 Financial Results BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and the broader biopharma markets, today announced financial results for the three months ended March 31, 2024 and affirmed its revenue guidance for 2024.
Thu, 02 May 2024 14:01:13 +0000	BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release BioLife Solutions (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue, 30 Apr 2024 20:12:00 +0000	BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business
Thu, 18 Apr 2024 15:00:49 +0000	Insider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ... BioLife Solutions Inc (NASDAQ:BLFS) Chief Marketing Officer Todd Berard has sold 10,000 shares of the company on April 15, 2024, according to a recent SEC Filing.
Thu, 18 Apr 2024 12:05:00 +0000	BioLife Solutions Announces the Divestiture of its Stirling Freezer Business BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") and the broader biopharma markets, today announced that it has completed the divestiture of its wholly owned subsidiary Global Cooling, Inc. ("GCI" or "Stirling").
Fri, 29 Mar 2024 10:39:17 +0000	Investors in BioLife Solutions (NASDAQ:BLFS) have unfortunately lost 49% over the last three years BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders should be happy to see the share price up 14% in the last quarter...
Wed, 27 Mar 2024 20:37:08 +0000	Corporate Insiders Are Selling These 10 Small-Cap Stocks In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders Are Selling These 5 Small-Cap Stocks. When the inflation crisis started and the Federal Reserve began raising interest rates, investors were quick to exit small-cap stocks which are deemed […]
Thu, 14 Mar 2024 06:15:04 +0000	Director Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS) BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sale according to a recent SEC filing.
Wed, 13 Mar 2024 05:50:09 +0000	Insider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS) BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sell according to the latest SEC filings.
Fri, 08 Mar 2024 18:58:42 +0000	When Will BioLife Solutions, Inc. (NASDAQ:BLFS) Become Profitable? BioLife Solutions, Inc. ( NASDAQ:BLFS ) is possibly approaching a major achievement in its business, so we would like...
Mon, 04 Mar 2024 13:03:00 +0000	BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that Roderick de Greef, Chief Executive Officer, and Troy Wichterman, Chief Financial Officer, will present and meet with current and prospective investors at the following March Investor Conferences.
Sat, 02 Mar 2024 13:16:17 +0000	BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript February 29, 2024 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.36. BioLife Solutions, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
Fri, 01 Mar 2024 11:02:57 +0000	Q4 2023 BioLife Solutions Inc Earnings Call Q4 2023 BioLife Solutions Inc Earnings Call
Thu, 29 Feb 2024 21:03:00 +0000	BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the fourth quarter and year ended December 31, 2023, and introduces 2024 revenue guidance.
Tue, 20 Feb 2024 13:03:00 +0000	BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2023 financial results will be released after market close on Thursday, February 29, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and gi
Sat, 17 Feb 2024 12:27:45 +0000	Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now? While BioLife Solutions, Inc. ( NASDAQ:BLFS ) might not have the largest market cap around , it saw a significant share...
Fri, 19 Jan 2024 10:10:28 +0000	Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 36% Undervaluation? Key Insights The projected fair value for BioLife Solutions is US$26.50 based on 2 Stage Free Cash Flow to Equity...